Edition:
United States

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

53.88USD
24 Feb 2017
Change (% chg)

$0.30 (+0.56%)
Prev Close
$53.58
Open
$53.55
Day's High
$53.90
Day's Low
$53.20
Volume
1,235,446
Avg. Vol
916,709
52-wk High
$56.50
52-wk Low
$39.35

ZTS.N

Chart for ZTS.N

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively,... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $26,507.02
Shares Outstanding(Mil.): 491.96
Dividend: 0.10
Yield (%): 0.78

Financials

  ZTS.N Industry Sector
P/E (TTM): 32.70 28.90 29.71
EPS (TTM): 1.65 -- --
ROI: 12.97 13.43 12.94
ROE: 64.27 14.33 14.09

BRIEF-Zoetis reports Q4 EPS $0.31

* Q4 earnings per share view $0.45 -- Thomson Reuters I/B/E/S

Feb 16 2017

BRIEF-Zoetis receives European commission approval for stronghold plus

* Zoetis receives European commission approval for stronghold plus Source text for Eikon: Further company coverage:

Feb 15 2017

BRIEF-Pershing Square dissolves sole share stake in Zoetis Inc

* Pershing Square Capital Management dissolves sole share stake in Zoetis Inc - SEC filing

Feb 14 2017

BRIEF-Zoetis sees Q3 adjusted EPS $0.52

* Zoetis inc- increases diluted eps to $1.66 - $1.75 on a reported basis, or $1.91 - $1.96 on an adjusted basis for full year 2016

Nov 02 2016

UPDATE 1-MOVES-Pershing Square's Valeant analyst to exit, Ackman sees stock rising

BOSTON, Aug 26 Billionaire investor William Ackman said on Friday that Jordan Rubin, who had worked closely on Pershing Square Capital Management's controversial investment in battered drug maker Valeant Pharmaceuticals, is leaving the hedge fund.

Aug 26 2016

More From Around the Web

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $66.16 +0.31
Bayer AG (BAYGn.DE) €104.25 -0.85
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €80.58 +0.45
Eli Lilly and Co (LLY.N) $82.87 +0.32

Earnings vs. Estimates